Genetic Analysis of Melanoma Types Using Japanese Genomic Database
The Laryngoscope · 2024
DOI: 10.1002/lary.31676 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Hayato Matsumoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. Hauptthemen laut MEDLINE: Melanoma, Mutation, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
The purpose of this study is to compare genetic mutations, tumor mutation burden (TMB), and the effects of molecular targeted drugs and immune checkpoint inhibitors (ICIs) in head and neck mucosal melanoma (HNMUM) with those in skin melanoma (SKM) and ocular melanoma (OM).
Methods
Data were analyzed for 72 consecutive patients with HNMUM, including 366 with SKM and 31 with OM, registered at the Japan National Cancer Center, Center for Cancer Genomics and Advanced Therapeutics (C‐CAT) between June 2019 and October 2023. Genetic alterations and TMB were determined by FoundationOne CDx next‐generation sequencing.
Results
The top 10 mutations in HNMUM were RAD21 (47.2%), NBN (45.8%), MYC (40.3%), LYN (31.9%), NRAS (29.1%), IRF4 (23.6%), DAXX (22.2%), KIT (22.2%), NOTCH3 (20.8%), and DDR1 (19.4%), with 16.6 ± 0.8 (mean ± SEM) mutations/individual. In SKM, BRAF ( p = 0.04) mutation was associated with a significantly better prognosis. The TMB values were 5.7 ± 2.1 (mean ± SEM) in HNMUM, 4.1 ± 0.2 in SKM, and 3.4 ± 0.9 in OM, with no significant differences among the three groups. The median survival time for patients with distant metastases was 803 (95% confidence interval: 539‐NA) days for HNMUM, 1413 (831–2172) days for SKM, and 1138 (438‐NA) days for OM.
Conclusions
The top 10 mutations in HNMUM are closer to those in OM than those in SKM. There was no significant difference in TMB values or survival rates with regard to the therapeutic effect of ICIs among the diseases, which suggests that current treatment of HNMUM with ICIs is appropriate. Level of Evidence 3 Laryngoscope , 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
ORCID-Profile: Hayato Matsumoto, Hiromi Nagano
Zitieren
APA
Matsumoto, H., Nagano, H., Kyutoku, T., & Yamashita, M. (2024). Genetic Analysis of Melanoma Types Using Japanese Genomic Database. The Laryngoscope. https://doi.org/10.1002/lary.31676
Vancouver
Matsumoto H, Nagano H, Kyutoku T, Yamashita M. Genetic Analysis of Melanoma Types Using Japanese Genomic Database. The Laryngoscope. 2024. doi:10.1002/lary.31676
BibTeX
@article{Matsumoto2024,
author = {Matsumoto, Hayato and Nagano, Hiromi and Kyutoku, Takayuki and Yamashita, Masaru},
title = {Genetic Analysis of Melanoma Types Using Japanese Genomic Database},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31676}
}
EUVIMED